Atlas Trials

A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and Safety

Clinical trial NCT02491528 · COMPLETED

Trial details

NCT number
NCT02491528
Sponsor
Tonghua Dongbao Pharmaceutical Co.,Ltd
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes
Start date
2015-06-19
Primary completion
2016-08-12
Enrollment
563

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.